Kevin Flanigan

Person

Columbus, OH, US

People

Patents Grantslast 30 patents

Information Patent Grant
Recombinant adeno-associated virus delivery of exon 2-targeted U7SN...
- Patent number 11,230,707
- Issue date Jan 25, 2022
- Research Institute at Nationwide Children's Hospital
- Kevin Flanigan
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods and materials for activating an internal ribosome entry sit...
- Patent number 11,053,494
- Issue date Jul 6, 2021
- Research Institute at Nationwide Children's Hospital
- Kevin Flanigan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Recombinant adeno-associated virus delivery of exon 2-targeted U7SN...
- Patent number 9,862,945
- Issue date Jan 9, 2018
- Research Institute at Nationwide Children's Hospital
- Kevin Flanigan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20240261434
- Publication date Aug 8, 2024
- Research Institute at Nationwide Children's Hospital
- Kevin Flanigan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PRODUCTS AND METHODS FOR TREATMENT OF DYSTROPHIN-BASED MYOPATHIES U...
- Publication number 20240254509
- Publication date Aug 1, 2024
- Research Institute at Nationwide Children's Hospital
- Kevin Flanigan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PRODUCTS AND METHODS FOR INDUCING EXON 2 SKIPPING OF THE DMD GENE I...
- Publication number 20240209360
- Publication date Jun 27, 2024
- Research Institute at Nationwide Children's Hospital
- Kevin Flanigan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY
- Publication number 20240200066
- Publication date Jun 20, 2024
- Research Institute at Nationwide Children's Hospital
- Nicolas Sebastien Wein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MATERIALS AND METHODS FOR NEUROFIBROMIN 2/MERLIN (NF2) GENE THERAPY
- Publication number 20240189453
- Publication date Jun 13, 2024
- Research Institute at Nationwide Children's Hospital
- Long-Sheng Chang
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AAV-MEDIATED HOMOLOGY-INDEPENDENT TARGETED INTEGRATION GENE EDITING...
- Publication number 20230357795
- Publication date Nov 9, 2023
- Research Institute at Nationwide Children's Hospital
- Kevin Flanigan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Recombinant Adeno-Associated Virus Delivery of Exon 2-Targeted U7SN...
- Publication number 20230025574
- Publication date Jan 26, 2023
- Research Institute at Nationwide Children's Hospital
- Kevin Flanigan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
EXON 44-TARGETED NUCLEIC ACIDS AND RECOMBINANT ADENO-ASSOCIATED VIR...
- Publication number 20220282247
- Publication date Sep 8, 2022
- Research Institute at Nationwide Children's Hospital
- Nicolas Sebastien Wein
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
METHODS AND MATERIALS FOR ACTIVATING AN INTERNAL RIBOSOME ENTRY SIT...
- Publication number 20220127607
- Publication date Apr 28, 2022
- Research Institute at Nationwide Children's Hospital
- Kevin Flanigan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
Recombinant Adeno-Associated Virus Delivery of Exon 2-Targeted U7SN...
- Publication number 20190276822
- Publication date Sep 12, 2019
- Research Institute at Nationwide Children's Hospital
- Kevin Flanigan
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS AND MATERIALS FOR ACTIVATING AN INTERNAL RIBOSOME ENTRY SIT...
- Publication number 20170218366
- Publication date Aug 3, 2017
- Kevin Flanigan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
RECOMBINANT ADENO-ASSOCIATED VIRUS DELIVERY OF EXON 2-TARGETED U7SN...
- Publication number 20160076028
- Publication date Mar 17, 2016
- Research Institute at Nationwide Children's Hospital
- Kevin Flanigan
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...

Kevin Flanigan

Person

Patents Grantslast 30 patents

Recombinant adeno-associated virus delivery of exon 2-targeted U7SN...

Methods and materials for activating an internal ribosome entry sit...

Recombinant adeno-associated virus delivery of exon 2-targeted U7SN...

Patents Applicationslast 30 patents

PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY

PRODUCTS AND METHODS FOR TREATMENT OF DYSTROPHIN-BASED MYOPATHIES U...

PRODUCTS AND METHODS FOR INDUCING EXON 2 SKIPPING OF THE DMD GENE I...

PRODUCTS AND METHODS FOR TREATING MUSCULAR DYSTROPHY

MATERIALS AND METHODS FOR NEUROFIBROMIN 2/MERLIN (NF2) GENE THERAPY

AAV-MEDIATED HOMOLOGY-INDEPENDENT TARGETED INTEGRATION GENE EDITING...

Recombinant Adeno-Associated Virus Delivery of Exon 2-Targeted U7SN...

EXON 44-TARGETED NUCLEIC ACIDS AND RECOMBINANT ADENO-ASSOCIATED VIR...

METHODS AND MATERIALS FOR ACTIVATING AN INTERNAL RIBOSOME ENTRY SIT...

Recombinant Adeno-Associated Virus Delivery of Exon 2-Targeted U7SN...

METHODS AND MATERIALS FOR ACTIVATING AN INTERNAL RIBOSOME ENTRY SIT...

RECOMBINANT ADENO-ASSOCIATED VIRUS DELIVERY OF EXON 2-TARGETED U7SN...